Mechanisms of Ultrasound Neuromodulation Effects in Diabetes
RecruitingNCT06042517Phase: NAStarted 2023-09-30
Summary
This study aims to evaluate the effect of hepatic ultrasound treatment on changes from baseline in whole-body insulin sensitivity during a hyperinsulinemic, euglycemic clamp (HE Clamp).
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
80 Years
Locations
Yale School of MedicineNew Haven, Connecticut, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06042517